Morgan Stanley analyst Bob Huang raised the firm’s price target on MetLife (MET) to $97 from $94 and keeps an Overweight rating on the shares. The firm said its price target changes for the Life Insurance sector reflect tailwinds from higher equity markets and headwinds related to Fed cuts.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MET:
- MetLife Announces Preliminary Q3 2025 Investment Income
- Intel downgraded, Tesla upgraded: Wall Street’s top analyst calls
- MetLife downgraded to Neutral from Overweight at Piper Sandler
- MetLife Advises Against Potemkin’s Mini-Tender Offer
- Wolfe Research launches coverage with positive view on Life Insurance names